ANIK
Anika Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$20.81
−1.05%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $0.17
- Revenue estimate
- $29.4M
Latest reported
- Last report date
- Jul 29, 2026
- EPS actual
- $0.42
- EPS estimate
- $0.03
- Revenue actual
- $32.6M
- Revenue estimate
- $29.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +599.9%
- Revenue beats (12Q)
- 8
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 29, 2026 | $0.03 | $0.42 | Beat 1300.00% | $32.6M |
| Apr 29, 2026 | -$0.07 | $0.27 | Beat 485.71% | $29.6M |
| Feb 26, 2026 | $0.02 | $0.12 | Beat 514.00% | $30.6M |
| Nov 5, 2025 | $0.02 | $0.04 | Beat 100.00% | $27.8M |
| Jul 30, 2025 | -$0.13 | -$0.13 | In line | $28.2M |
| May 9, 2025 | $0.09 | -$0.06 | Miss -166.67% | $26.2M |
| Mar 12, 2025 | -$0.01 | -$0.03 | Miss -200.00% | -$1.3M |
| Oct 31, 2024 | $0.30 | -$0.25 | Miss -183.33% | $38.8M |
| Mar 13, 2024 | -$0.26 | -$4.30 | Miss -1553.85% | $43.0M |
| Nov 2, 2023 | -$0.33 | -$0.45 | Miss -36.36% | $41.5M |
| Mar 6, 2023 | -$0.22 | -$0.34 | Miss -54.55% | $39.6M |
| Aug 3, 2022 | -$0.26 | -$0.20 | Beat 23.08% | $39.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026